Abstract
Background: Glutathione synthetase (GS) deficiency is a rare inborn error of glutathione (GSH) metabolism manifested by severe metabolic acidosis, hemolytic anemia, neurological problems and massive excretion of pyroglutamic acid (5-oxoproline) in the urine. The disorder has mild, moderate, and severe clinical variants. We aimed to report clinical and laboratory findings of four patients, effect of sodium hydrogen carbonate treatment and long-term follow up of three patients.
Methods: Urine organic acid analysis was performed with gas chromatography-mass spectrometry. Molecular genetic analysis was performed in three patients, mutation was found in two of them. Enzyme analysis was performed in one patient. Clinical and laboratory findings of four patients were evaluated.
Results: One patient died at 4 months old, one patient’s growth and development are normal, two patients have developed intellectual disability and seizures in the long term follow up period. Three patients benefited from sodium hydrogen carbonate treatment.
Conclusions: The clinical picture varies from patient to patient, so it is difficult to predict the prognosis and the effectiveness of treatment protocols. We reported long term follow up of four patients and demonstrated that sodium hydrogen carbonate is effective for treatment of chronic metabolic acidosis in GS deficieny.
References
1. Mayatepek E, Jaeken J. Disorders in the metabolism of glutathione and ımidazole dipeptides. In: Saudubray JM, van den Berghe G, Walter JH, editors. Inborn metabolic diseases, 5th ed. Berlin, Heidelberg: Springer-Verlag, 2011:424–30.Search in Google Scholar
2. Ristoff E, Larsson A. Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis 2007;2:16.10.1186/1750-1172-2-16Search in Google Scholar PubMed PubMed Central
3. Simon E, Vogel M, Fingerhut R, Ristoff E, Mayatepek E, Spiekerkötter U. Diagnosis of glutathione synthetase deficiency in newborn screening. J Inherit Metab Dis 2009;32 (Suppl 1):S269–72.10.1007/s10545-009-1213-xSearch in Google Scholar PubMed
4. Hussain K, Thornton PS, Otonkoski T, Aynsley-Green A. Severe transient neonatal hyperinsulinism associated with hyperlactataemia in non-asphyxiated infants. J Pediatr Endocrinol Metab 2004;17:203–9.10.1515/JPEM.2004.17.2.203Search in Google Scholar
5. Messina MF, Lombardo F, Crisafulli G, Salzano G, Rosano M, Di Giorgio RM. Hemolytic crisis in a non-ketotic and euglycemic child with glucose-6-phosphate dehydrogenase deficiency and onset of type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004;17:1671–3.10.1515/JPEM.2004.17.12.1671Search in Google Scholar PubMed
6. Kurtoglu S, Hatipoglu N, Keskin M, Kendirci M, Akcakus M. Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings. J Pediatr Endocrinol Metab 2008;21:393–7.10.1515/JPEM.2008.21.4.393Search in Google Scholar
7. Njålsson R, Ristoff E, Carlsson K, Winkler A, Larsson A, Norgren S. Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency. Hum Genet 2005;116:384–9.10.1007/s00439-005-1255-6Search in Google Scholar PubMed
8. Li X, Ding Y, Liu Y, Ma Y, Song J, Wang Q, et al. Five Chinese patients with 5-oxoprolinuria due to glutathione synthetase and 5-oxoprolinase deficiencies. Brain Dev 2015;37:952–9.10.1016/j.braindev.2015.03.005Search in Google Scholar PubMed
9. Ben Ameur S, Aloulou H, Nasrallah F, Kamoun T, Kaabachi N, Hachicha M. Hemolytic anemia and metabolic acidosis: think about glutathione synthetase deficiency. Fetal Pediatr Pathol 2015;34:18–20.10.3109/15513815.2014.947543Search in Google Scholar PubMed
©2016 by De Gruyter
